mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |